ADMA vs MSFT: Which Stock is Better?
Side-by-side comparison of Adma Biologics Inc and Microsoft Corp in 2026
ADMA
Adma Biologics Inc
$17.59
MSFT
Microsoft Corp
$454.79
Key Metrics Comparison
| Metric | ADMA | MSFT | Winner |
|---|---|---|---|
| Market Cap | $4.20B | $3.38T | MSFT |
| P/E Ratio | 20.45 | 36.30 | ADMA |
| EPS (TTM) | $0.86 | $13.70 | MSFT |
| Revenue Growth | 0.1% | 14.9% | MSFT |
| Gross Margin | 54.7% | 68.8% | MSFT |
Analyze ADMA
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADMA or MSFT a better investment?
Comparing ADMA and MSFT: Adma Biologics Inc has a market cap of $4.20B while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADMA and MSFT?
ADMA (Adma Biologics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADMA or MSFT?
Based on P/E ratios, ADMA trades at a lower multiple (20.5x vs 36.3x).
Which is growing faster: ADMA or MSFT?
MSFT has higher revenue growth at 14.9% vs 0.1% for ADMA.
Which company is more profitable: ADMA or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 54.7% for ADMA.
Which is the larger company: ADMA or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $4.20B for ADMA.
Should I buy ADMA or MSFT in 2026?
Both ADMA and MSFT have investment merit. ADMA trades at $17.59 while MSFT trades at $454.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADMA and MSFT stock?
Key differences: Market Cap ($4.20B vs $3.38T), P/E Ratio (20.5x vs 36.3x), Revenue Growth (0.1% vs 14.9%), Gross Margin (54.7% vs 68.8%).